Luke Adam Monteagudo, Aaron B Boothby, E. Gertner
2020.4.8ACR Open Rheumatology
tlooto Summary
The objective of this study was to report the benefit of a therapeutic approach consisting of intravenous (IV) continuous anakinra (recombinant human interleukin‐1 receptor antagonist) infusions in treating severely ill adult patients with secondary hemophagocytic lymphohistiocytosis or macrophage activation syndrome.
Abstract
The objective of this study was to report the benefit of a therapeutic approach consisting of intravenous (IV) continuous anakinra (recombinant human interleukin‐1 receptor antagonist) infusions in treating severely ill adult patients with secondary hemophagocytic lymphohistiocytosis or macrophage activation syndrome (MAS).
Citation format
MONTEAGUDO, Luke Adam; BOOTHBY, Aaron B; GERTNER, E. Continuous intravenous anakinra infusion to calm the cytokine storm in macrophage activation syndrome. ACR Open Rheumatology, 2020, 2: 276–282.